Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

CC4075 Human Plasminogen activator inhibitor-1, recombinant

MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Key Applications: Activity Assay, Inhibits Activity/Function UniProt Number: P05121 Entrez Gene Number: NM_000602
CC4075
50 µg  
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Catalogue NumberCC4075
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionHuman Plasminogen activator inhibitor-1, recombinant
OverviewThe sequence corresponding to amino acids 24 to 402 of human PAI-1 (mature form) tagged with 6xHis on the carboxy-terminal was expressed in E. Coli.
Alternate Names
  • PAI 1
  • SERPINE1
  • PAI1
Background InformationPlasminogen activator inhibitor-1 (PAI-1) is a member of the serine protease inhibitor (serpin) superfamily and a central regulatory protein in the blood coagulation system. PAI-1 is unique among serpins in exhibiting distinct active and inactive (latent) conformations in vivo. Human PAI-1 is a single-chain glycoprotein with a molecular weight of 43 kDa. This inhibitor acts as "bait" for tissue-type and urokinase-type plasminogen activators (tPA and uPA) and protein C. Its rapid interaction with tPA may function as a major control point in the regulation of fibrinolysis. The highly mobile reactive-center loop (RCL) is thought to account for both the rapid inhibiton of plasminogen activators, and the rapid and spontaneous transition of the unstable, active form of PAI-1 into the stable, inactive conformation (t1/2 at 37oC, 2 hours). The inactive form can be partially reactivated by denaturants such as urea, guanidine hydrochloride or SDS. High concentrations of PAI-1 have been associated with human thromboembolic disease. PAI-1 activity may limit the extent of tumor metastasis, since uPA activity is a major contributory factor promoting dissolution of tumor matrix and basement membrane.
References
Product Information
PresentationLiquid. In 150 mM Na2HPO4, pH 6.6, 500 mM NaCl, 2 mM Glutathione, and 0.01% Tween-80.
Quality LevelMQ100
Applications
Key Applications
  • Activity Assay
  • Inhibits Activity/Function
Biological Information
Purity>/=98%, as determined by SDS-PAGE gel electrophores. Endotoxin level: < 1EU/microgram.
Specific ActivityBy uPA activity assay, the recombinant PAI-1 contains a mixture of the active and latent forms, with > 45% of active form. To fully activate the latent PAI-1, the PAI-1 must be incubated in Activation Buffer (2X Activation Buffer: 8 M Guanidine HCl, 40 mM Sodium Acetate, pH 5.6, 400 mM NaCl, 0.2% Tween 20) for 15 to 30 minutes (Sancho, 1994). The recombinant PAI-1 is able to bind to uPA resulting in a SDS-stable complex.
Entrez Gene Number
Entrez Gene SummaryPlasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones.
Gene Symbol
  • PAI
  • PAI1
  • PAI-1
  • PLANH1
  • SERPINE1
UniProt Number
UniProt SummaryFUNCTION: This inhibitor acts as 'bait' for tissue plasminogen activator, urokinase, and protein C. Its rapid interaction with TPA may function as a major control point in the regulation of fibrinolysis.
SUBUNIT STRUCTURE: Interacts with VTN. Binds LRP1B; binding is followed by internalization and degradation.
SUBCELLULAR LOCATION: Secreted.
TISSUE SPECIFICITY: Found in plasma and platelets and in endothelial, hepatoma and fibrosarcoma cells.
PTMs: Inactivated by proteolytic attack of the urokinase-type (u-PA) and the tissue-type (TPA), cleaving the 369-Arg-|-Met-370 bond.
DISEASE: Defects in SERPINE1 are the cause of plasminogen activator inhibitor-1 deficiency (PAI-1 deficiency) [MIM:173360]. This deficiency is characterized by abnormal bleeding due to SERPINE1 defect in the plasma.
High concentrations of SERPINE1 have been associated with thrombophilia [MIM:188050]; an autosomal dominant disorder in which affected individuals are prone to develop serious spontaneous thrombosis.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStore at -80ºC. Thaw on ice and freeze aliquots at -80ºC for longer storage. This product is stable for at least 2 years as supplied. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size50 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
CC4075 04053252620546

Documentation

Protocols

Title
MMP Activation Chart

Human Plasminogen activator inhibitor-1, recombinant SDS

Title

Safety Data Sheet (SDS) 

Human Plasminogen activator inhibitor-1, recombinant Certificates of Analysis

TitleLot Number
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] RECOMBINANT PROTEIN - 2318098 2318098
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] RECOMBINANT PROTEIN - 2433410 2433410
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3173548 3173548
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3559004 3559004
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3819959 3819959
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3905457 3905457
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 3922568 3922568
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] - 4117354 4117354
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] -2601679 2601679
HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-1 [PAI-1] -2766482 2766482
Show more

References

Reference overviewPub Med ID
Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center.
Sherman, P M, et al.
J. Biol. Chem., 267: 7588-95 (1992)  1992

Show Abstract 		1559996 1559996